|
Streptococcus pneumoniae
|
B03.353.750.737.872.550 |
|
|
Polycomb Repressive Complex 2
|
D12.776.660.235.600.200 |
|
|
Polycomb-Group Proteins
|
D12.776.660.235.600 |
|
|
Rejuvenation
|
D012060 |
[The phenomenon of youthfulness, vitality, and freshness being restored. This can apply to appearance, TISSUES, organ functions, or other areas.
] |
|
Relapsing Fever
|
D012061 |
[An acute infection characterized by recurrent episodes of PYREXIA alternating with asymptomatic intervals of apparent recovery. This condition is caused by SPIROCHETES of the genus BORRELIA. It is transmitted by the BITES of either the body louse (PEDICULUS humanus corporis), for which humans are the reservoir, or by soft ticks of the genus ORNITHODOROS, for which rodents and other animals are the principal reservoirs.
] |
|
Relative Biological Effectiveness
|
D012062 |
[The ratio of radiation dosages required to produce identical change based on a formula comparing other types of radiation with that of gamma or roentgen rays.
] |
|
Beclomethasone
|
D04.210.500.745.432.769.125 |
|
|
Pregnadienetriols
|
D04.210.500.745.432.769 |
|
|
Advisory Committees
|
D026683 |
[Groups set up to advise governmental bodies, societies, or other institutions on policy. (Bioethics Thesaurus)
, Committees established to monitor compliance with standards or policies.
] |
|
Personal Autonomy
|
D026684 |
[Self-directing freedom and especially moral independence. An ethical principle holds that the autonomy of persons ought to be respected. (Bioethics Thesaurus)
] |
|
MART-1 Antigen
|
D12.776.624.301.750 |
|
|
Melanoma-Specific Antigens
|
D12.776.624.301 |
|
|
Beneficence
|
D026686 |
[In ethics, the principle that requires avoiding the causation of harm.
, The state or quality of being kind, charitable, or beneficial. (from American Heritage Dictionary of the English Language, 4th ed). The ethical principle of BENEFICENCE requires producing net benefit over harm. (Bioethics Thesaurus)
] |
|
Bioethical Issues
|
D026688 |
[Clusters of topics that fall within the domain of BIOETHICS, the field of study concerned with value questions that arise in biomedicine and health care delivery.
] |
|
Ethical Analysis
|
D026689 |
[The use of systematic methods of ethical examination, such as CASUISTRY or ETHICAL THEORY, in reasoning about moral problems.
] |
|
Fagus
|
B01.650.940.800.575.912.250.859.750.300.249 |
|
|
Ethics, Clinical
|
D026690 |
[The identification, analysis, and resolution of moral problems that arise in the care of patients. (Bioethics Thesaurus)
] |
|
Mass Vaccination
|
N02.421.726.608.500 |
|
|
Immunization Programs
|
N02.421.726.608 |
|
|
ADP Ribose Transferases
|
D036002 |
[Enzymes that transfer the ADP-RIBOSE group of NAD or NADP to proteins or other small molecules. Transfer of ADP-ribose to water (i.e., hydrolysis) is catalyzed by the NADASES. The mono(ADP-ribose)transferases transfer a single ADP-ribose. POLY(ADP-RIBOSE) POLYMERASES transfer multiple units of ADP-ribose to protein targets, building POLY ADENOSINE DIPHOSPHATE RIBOSE in linear or branched chains.
, An enzyme that catalyze the transfer of ADP-RIBOSE from NAD+ to an amino acid residue in a specific protein substrate. This reaction is catalyzed by both mono(ADP-ribose) transferases as well as POLY(ADP-RIBOSE) POLYMERASES. When the term NAD+ ADP-Ribosyltransferase refers to EC 2.4.2.30 it is referring to POLY(ADP-RIBOSE) POLYMERASES.
, Enzymes that catalyze the transfer of one ADP-ribose moiety from NAD+ to an amino acid residue in specific protein substrates. This reaction is catalyzed by prokaryotic and eukaryotic enzymes. Mono-ADP-ribosylation is a mechanism of action common to several bacterial toxins.
, An enzyme that catalyzes the transfer of the ADP-ribose moiety from NAD+ or NADP+ to specific protein substrates with arginine, arginine-type compounds, agmatine, or guanidine as acceptors. This mono-ADP-ribosylation reaction is the mechanism of action common to several bacterial toxins affecting profound changes in cellular metabolism, such as activation of adenylate cyclase, regulation of protein synthesis at the level of elongation factor 2, and ion transport across biological membranes.
] |
